Literature DB >> 12958044

Cyclosporin A enhances interleukin-8 expression by inducing activator protein-1 in human aortic smooth muscle cells.

Ryuichiro Murakami1, Fukushi Kambe, Hirohito Mitsuyama, Kenji Okumura, Toyoaki Murohara, Satoru Niwata, Ryohei Yamamoto, Hisao Seo.   

Abstract

OBJECTIVE: Cyclosporin A (CsA) and tacrolimus (FK506) are widely used as immunosuppressants. However, their use has been hampered by various adverse effects, such as acceleration of atherosclerosis. Interleukin (IL)-8, a chemotactic cytokine, plays an important role in pathogenesis of atherosclerosis. We thus investigated whether synthesis of IL-8 from primary human aortic smooth muscle cells is influenced by CsA and FK506. METHODS AND
RESULTS: Northern blot analysis revealed that CsA increased IL-8 mRNA level and enhanced its increase by epidermal growth factor or tumor necrosis factor-alpha. In contrast, FK506 had no effect on the mRNA level. IL-8 accumulation in culture media was also increased by CsA. Stability of IL-8 mRNA was not affected by CsA, whereas luciferase reporter gene assay using the human IL-8 promoter revealed that CsA significantly augmented the promoter activity. Electrophoretic mobility shift assay showed that binding activity of activator protein (AP)-1 was increased by CsA, and introduction of a mutation into the AP-1 site in the promoter abolished its CsA-dependent activation. The increased AP-1 binding activity was accompanied by c-Fos synthesis.
CONCLUSIONS: CsA stimulates synthesis of IL-8 via activation of AP-1 in human aortic smooth muscle cells, providing a novel aspect of biological effects of CsA on the cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12958044     DOI: 10.1161/01.ATV.0000094234.60166.78

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  6 in total

1.  Effects of immunomodulatory drugs on plasma inflammatory markers in a rabbit model of atherosclerosis.

Authors:  Maha E Houssen; Mona M Haron; Sheren S Metwally; Tarek M Ibrahim
Journal:  J Physiol Biochem       Date:  2010-10-20       Impact factor: 4.158

2.  Altered VEGF mRNA stability following treatments with immunosuppressive agents: implications for cancer development.

Authors:  Aninda Basu; Dipak Datta; David Zurakowski; Soumitro Pal
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

3.  Calcineurin inhibitors exacerbate coronary arteritis via the MyD88 signalling pathway in a murine model of Kawasaki disease.

Authors:  K Murata; Y Motomura; T Tanaka; S Kanno; T Yano; M Onimaru; A Shimoyama; H Nishio; Y Sakai; M Oh-Hora; H Hara; K Fukase; H Takada; S Masuda; S Ohga; S Yamasaki; T Hara
Journal:  Clin Exp Immunol       Date:  2017-07-21       Impact factor: 4.330

Review 4.  Immunological aspects of atherosclerosis.

Authors:  S Garrido-Urbani; M Meguenani; F Montecucco; B A Imhof
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

5.  Amniotic membrane matrix effects on calcineurin-NFAT-related gene expressions of SHED treated with VEGF for endothelial differentiation.

Authors:  Siti Nurnasihah Md Hashim; Muhammad Fuad Hilmi Yusof; Wafa' Zahari; Khairul Bariah Ahmad Amin Noordin; Tetsuya Akamatsu; Ahmad Azlina
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-05-21       Impact factor: 2.416

6.  Hypothermia Promotes Interleukin-22 Expression and Fine-Tunes Its Biological Activity.

Authors:  Evgeny Chichelnitskiy; Britta Himmelseher; Malte Bachmann; Josef Pfeilschifter; Heiko Mühl
Journal:  Front Immunol       Date:  2017-06-29       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.